These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 3228706)
1. Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin. Steinheider G; Schaefer A; Westendorf J; Marquardt H Cell Biol Toxicol; 1988 Mar; 4(1):123-33. PubMed ID: 3228706 [TBL] [Abstract][Full Text] [Related]
2. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin. Steinheider G; Westendorf J; Marquardt H Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells. Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines. Schwartz EL; Sartorelli AC Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of amino acid uptake and incorporation into proteins in Friend erythroleukemia cells by the anthracycline antitumor antibiotic aclacinomycin A. Schaefer A; Boldt J; Westendorf J; Steinheider G; Marquardt H Biochem Pharmacol; 1988 Apr; 37(7):1377-82. PubMed ID: 3162677 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin. Morin MJ; Sartorelli AC Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026 [TBL] [Abstract][Full Text] [Related]
7. Activation of erythroid-specific promoters during anthracycline-induced differentiation of K562 cells. Aries A; Trentesaux C; Ottolenghi S; Jardillier JC; Jeannesson P; Doubeikovski A Blood; 1996 Apr; 87(7):2885-90. PubMed ID: 8639908 [TBL] [Abstract][Full Text] [Related]
8. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels. Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation. Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951 [TBL] [Abstract][Full Text] [Related]
10. Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A. Steinheider G; Westendorf J; Marquardt H Experientia; 1987 May; 43(5):586-8. PubMed ID: 3472901 [TBL] [Abstract][Full Text] [Related]
11. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells. Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880 [TBL] [Abstract][Full Text] [Related]
12. Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression. Jeannesson P; Lahlil R; Chenais B; Devy L; Gillet R; Aries A; Morceau F; Trentesaux C Leuk Lymphoma; 1997 Aug; 26(5-6):575-87. PubMed ID: 9389364 [TBL] [Abstract][Full Text] [Related]
13. Effects of several anthracycline antitumor antibiotics on the transcriptional activity of isolated nucleoli. DuVernay VH; Crooke ST J Antibiot (Tokyo); 1980 Sep; 33(9):1048-53. PubMed ID: 6160136 [TBL] [Abstract][Full Text] [Related]
14. Deoxyribonucleic acid binding studies on several new anthracycline antitumor antibiotics. Sequence preference and structure--activity relationships of marcellomycin and its analogues as compared to adriamycin. DuVernay VH; Pachter JA; Crooke ST Biochemistry; 1979 Sep; 18(18):4024-30. PubMed ID: 486409 [TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity in vivo and induction of mutagenesis and DNA repair in vitro by aclacinomycin A and marcellomycin: structure-activity relationship and predictive value of short-term tests. Westendorf J; Marquardt H; Ketkar MB; Mohr U; Marquardt H Cancer Res; 1983 Nov; 43(11):5248-51. PubMed ID: 6352017 [TBL] [Abstract][Full Text] [Related]
16. Induction of leukemia cell differentiation by chemotherapeutic agents. Schwartz EL; Ishiguro K; Sartorelli AC Adv Enzyme Regul; 1983; 21():3-20. PubMed ID: 6400065 [TBL] [Abstract][Full Text] [Related]
17. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line. Burres NS; Myers MT; Sartorelli AC Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331 [TBL] [Abstract][Full Text] [Related]
18. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells. Nyoung MN; Trentesaux C; Aries A; Carpentier Y; Jardillier JC; Gorisse MC; Jeannesson P Anticancer Res; 1994; 14(3A):1203-8. PubMed ID: 8074473 [TBL] [Abstract][Full Text] [Related]
19. Studies on aclacinomycin A resistance in mouse lymphoblastoma. Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828 [TBL] [Abstract][Full Text] [Related]